Table I.
Relationship between BAG-1 expression and clinicopathological characteristics of NSCLC patients.
| BAG-1 expression | ||||
|---|---|---|---|---|
|
|
||||
| n | Positive | Negative | P-value | |
| Subjects | ||||
| Healthy control | 120 | 14 | 106 | <0.05 |
| NSCLC | 120 | 86 | 34 | |
| Benign lung tumor | 10 | 1 | 9 | |
| Gender | ||||
| Male | 90 | 66 | 24 | >0.05 |
| Female | 28 | 20 | 8 | |
| Age (years) | ||||
| ≤52 | 56 | 42 | 14 | >0.05 |
| >52 | 64 | 44 | 20 | |
| Pathological types | ||||
| Squamous carcinoma | 62 | 44 | 18 | >0.05 |
| Adenocarcinoma | 58 | 42 | 16 | |
| Differentiation stage | ||||
| Moderate/high differentiation | 68 | 56 | 12 | <0.05 |
| Poor differentiation | 52 | 30 | 22 | |
| Clinical stage | ||||
| I + II | 90 | 66 | 24 | >0.05 |
| IIIA | 30 | 20 | 10 | |
| Node metastasis | ||||
| With lymph node metastasis | 78 | 50 | 28 | >0.05 |
| Without lymph node metastasis | 42 | 28 | 14 | |
Data are presented as the number of cases. P<0.05 (bold text) indicates statistically significant difference.